IL89145A - 5-substituted ornithine derivatives and pharmaceutical compositions containing them - Google Patents

5-substituted ornithine derivatives and pharmaceutical compositions containing them

Info

Publication number
IL89145A
IL89145A IL89145A IL8914589A IL89145A IL 89145 A IL89145 A IL 89145A IL 89145 A IL89145 A IL 89145A IL 8914589 A IL8914589 A IL 8914589A IL 89145 A IL89145 A IL 89145A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
ornithine derivatives
substituted ornithine
substituted
Prior art date
Application number
IL89145A
Other languages
English (en)
Other versions
IL89145A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL89145A0 publication Critical patent/IL89145A0/xx
Publication of IL89145A publication Critical patent/IL89145A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IL89145A 1988-02-05 1989-02-02 5-substituted ornithine derivatives and pharmaceutical compositions containing them IL89145A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88400275A EP0326766B1 (en) 1988-02-05 1988-02-05 5-substituted ornithine derivatives

Publications (2)

Publication Number Publication Date
IL89145A0 IL89145A0 (en) 1989-09-10
IL89145A true IL89145A (en) 1993-08-18

Family

ID=8200349

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89145A IL89145A (en) 1988-02-05 1989-02-02 5-substituted ornithine derivatives and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (1) US4902719A (da)
EP (1) EP0326766B1 (da)
JP (1) JP2816431B2 (da)
KR (1) KR0150634B1 (da)
CN (1) CN1027891C (da)
AR (1) AR244657A1 (da)
AT (1) ATE77367T1 (da)
AU (1) AU612229B2 (da)
CA (1) CA1311767C (da)
DE (1) DE3872213T2 (da)
DK (1) DK172113B1 (da)
ES (1) ES2041815T3 (da)
FI (1) FI90530C (da)
GR (1) GR3005551T3 (da)
HU (1) HU204770B (da)
IE (1) IE63162B1 (da)
IL (1) IL89145A (da)
NO (1) NO176242C (da)
NZ (1) NZ227783A (da)
PH (1) PH26422A (da)
PT (1) PT89637B (da)
ZA (1) ZA89833B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016035A1 (en) * 1990-04-26 1991-10-31 The Procter & Gamble Company Chelator compositions comprising alpha-diamine compounds
EP0609630A1 (en) * 1993-02-05 1994-08-10 Merrell Dow Pharmaceuticals Inc. Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of Alzheimer's disease
US5677350A (en) * 1995-06-07 1997-10-14 Wisconsin Alumni Research Foundation Inhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanes
GB9617822D0 (en) * 1996-08-27 1996-10-09 Lilly Industries Ltd Pharmaceutical compounds
US6566330B1 (en) 1996-10-22 2003-05-20 Medical University Of South Carolina Foundation Research Development Positively charged non-natural amino acids, methods of making and using thereof in peptides
US6043218A (en) 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
US7166234B1 (en) * 2000-10-26 2007-01-23 Integrated Biomedical Technology, Inc. Dialdehyde assay
US6911544B2 (en) * 2002-10-23 2005-06-28 Pfizer Inc. Process for the preparation of (S,S)-cis-2-phenyl-3-aminopiperidine
EP3062175B1 (en) 2013-10-21 2018-09-05 Fuji Electric Co., Ltd. Control system design assist device, control system design assist program, control system design assist method, operation change amount calculation device, and control device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1091661A (en) * 1977-07-11 1980-12-16 Philippe Bey .alpha.-HALOMETHYL DERIVATIVES OF .alpha.-AMINO ACIDS
US4326071A (en) * 1977-09-28 1982-04-20 Merrell Toraude Et Compagnie Halomethyl derivatives of gamma-aminobutyric acid and related compounds
PH16634A (en) * 1980-06-16 1983-12-05 Merrell Dow Pharma Method of inhibiting the growth of protozoa
US4668703A (en) * 1983-07-07 1987-05-26 Syntex (U.S.A.) Inc. γ-allenyl-γ-aminobutyric acids

Also Published As

Publication number Publication date
GR3005551T3 (da) 1993-06-07
FI890477A0 (fi) 1989-02-01
PT89637B (pt) 1994-02-28
ZA89833B (en) 1989-10-25
DK172113B1 (da) 1997-11-10
CN1037142A (zh) 1989-11-15
EP0326766B1 (en) 1992-06-17
JPH021435A (ja) 1990-01-05
CA1311767C (en) 1992-12-22
US4902719A (en) 1990-02-20
HUT49320A (en) 1989-09-28
PT89637A (pt) 1989-10-04
KR0150634B1 (ko) 1998-10-15
IL89145A0 (en) 1989-09-10
KR890012942A (ko) 1989-09-20
HU204770B (en) 1992-02-28
ATE77367T1 (de) 1992-07-15
NO890455D0 (no) 1989-02-03
AU2951589A (en) 1989-08-10
JP2816431B2 (ja) 1998-10-27
EP0326766A1 (en) 1989-08-09
DE3872213T2 (de) 1993-01-28
PH26422A (en) 1992-07-15
AU612229B2 (en) 1991-07-04
DK51589D0 (da) 1989-02-03
DK51589A (da) 1989-08-06
CN1027891C (zh) 1995-03-15
IE63162B1 (en) 1995-03-22
IE890356L (en) 1989-08-05
FI90530C (fi) 1994-02-25
NO176242C (no) 1995-03-01
AR244657A1 (es) 1993-11-30
FI90530B (fi) 1993-11-15
NO176242B (no) 1994-11-21
NO890455L (no) 1989-08-07
FI890477A (fi) 1989-08-06
DE3872213D1 (de) 1992-07-23
ES2041815T3 (es) 1993-12-01
NZ227783A (en) 1990-12-21

Similar Documents

Publication Publication Date Title
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
IL91129A0 (en) Aminomethyloxooxazolidinyl arylbenzene derivatives,their preparation and pharmaceutical compositions containing them
IL90245A0 (en) Ethenediamine derivatives,their preparation and pharmaceutical compositions containing them
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
NZ220345A (en) Imidazoquinolinylether derivatives and pharmaceutical compositions containing them
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
IL90864A0 (en) Substituted 1,7-annelated 1h-indazoles,their preparation and pharmaceutical compositions containing them
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
IL88989A0 (en) 16-dehydro-vitamin d3 derivatives their preparation and pharmaceutical compositions containing them
IL82205A (en) Substituted alkane-sulfonamidophenyl derivatives and pharmaceutical compositions containing them
IL92710A0 (en) 2-iminobenzothiazoline derivatives,their preparation and pharmaceutical compositions containing them
IL92830A0 (en) Capsaicin derivatives,their preparation and pharmaceutical compositions containing them
IL90613A0 (en) Chroman derivatives and pharmaceutical compositions containing them
IL91245A0 (en) Benzopyranol derivatives,their preparation and pharmaceutical compositions containing them
IL89145A (en) 5-substituted ornithine derivatives and pharmaceutical compositions containing them
IL90002A0 (en) Phosphonoalkylpurine derivatives,their preparation and pharmaceutical compositions containing them
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
IL91709A0 (en) Substituted thienopyrans,their preparation and pharmaceutical compositions containing them
IL92326A0 (en) Substituted oxadiamino-butanes,their preparation and pharmaceutical compositions containing them
NZ223051A (en) Carbamoyloxylabdane derivatives and pharmaceutical compositions
NZ220541A (en) Tetrazole derivatives and pharmaceutical compositions
IL92107A0 (en) Quinazoline derivatives,and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.